Clinical Trial Update: Pirfenidone to Prevent Fibrosis in Ards. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pirfenidone to prevent fibrosis in acute respiratory distress syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Pirfenidone (Esbriet) (pirfenidone)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Status: RECRUITING